A detailed history of Kingsview Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 54,679 shares of LLY stock, worth $41.2 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
54,679
Previous 52,830 3.5%
Holding current value
$41.2 Million
Previous $47.8 Million 1.28%
% of portfolio
1.09%
Previous 1.2%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $1.43 Million - $1.78 Million
1,849 Added 3.5%
54,679 $48.4 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $1.59 Million - $2 Million
2,199 Added 4.34%
52,830 $47.8 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $841,516 - $1.13 Million
1,421 Added 2.89%
50,631 $39.4 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $3.62 Million - $4.27 Million
6,895 Added 16.29%
49,210 $28.7 Million
Q3 2023

Nov 07, 2023

SELL
$434.7 - $599.3 $1.35 Million - $1.86 Million
-3,110 Reduced 6.85%
42,315 $22.7 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $272,524 - $364,397
-777 Reduced 1.68%
45,425 $21.3 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $1.34 Million - $1.57 Million
4,309 Added 10.29%
46,202 $15.9 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $5.04 Million - $5.87 Million
15,671 Added 59.76%
41,893 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $461,915 - $526,401
1,558 Added 6.32%
26,222 $8.48 Million
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $2.96 Million - $3.48 Million
10,634 Added 75.79%
24,664 $8 Million
Q1 2022

Feb 08, 2024

BUY
$234.69 - $291.66 $644,928 - $801,481
2,748 Added 5.58%
51,958 $14.9 Million
Q4 2021

Feb 17, 2022

BUY
$224.85 - $279.04 $134,235 - $166,586
597 Added 4.44%
14,030 $3.88 Million
Q3 2021

Dec 03, 2021

SELL
$221.6 - $272.71 $1.85 Million - $2.28 Million
-8,361 Reduced 38.36%
13,433 $3.1 Million
Q2 2021

Aug 17, 2021

BUY
$180.55 - $233.54 $639,688 - $827,432
3,543 Added 19.41%
21,794 $5.04 Million
Q1 2021

May 24, 2021

BUY
$164.32 - $212.72 $1.16 Million - $1.5 Million
7,044 Added 62.85%
18,251 $3.38 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $752,232 - $995,384
5,766 Added 105.97%
11,207 $1.89 Million
Q3 2020

Nov 19, 2020

BUY
$146.22 - $169.13 $160,549 - $185,704
1,098 Added 25.28%
5,441 $805,000
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $141,740 - $170,583
-1,039 Reduced 19.31%
4,343 $713,000
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $298,101 - $368,964
2,504 Added 87.0%
5,382 $747,000
Q4 2019

Jan 31, 2020

BUY
$106.92 - $132.43 $307,715 - $381,133
2,878 New
2,878 $378,000
Q4 2019

Jan 30, 2020

SELL
$106.92 - $132.43 $384,591 - $476,350
-3,597 Closed
0 $0
Q3 2019

Jan 29, 2020

SELL
$106.79 - $116.16 $49,764 - $54,130
-466 Reduced 11.47%
3,597 $402,000
Q2 2019

Jan 29, 2020

SELL
$110.79 - $129.32 $47,861 - $55,866
-432 Reduced 9.61%
4,063 $450,000
Q1 2019

Jan 29, 2020

BUY
$111.31 - $131.02 $289,628 - $340,914
2,602 Added 137.45%
4,495 $583,000
Q4 2018

Jan 29, 2020

SELL
$105.9 - $118.64 $5,718 - $6,406
-54 Reduced 2.77%
1,893 $219,000
Q3 2018

Jan 29, 2020

BUY
$85.86 - $107.31 $167,169 - $208,932
1,947 New
1,947 $209,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.